Epidemiology, Clinical Manifestations, Treatment Approaches and Future Perspectives of Rift Valley Fever
Epidemiology of Rift Valley Fever
DOI:
https://doi.org/10.54393/pjhs.v4i04.603Keywords:
Rift valley fever, Epidemic, Livestock, Symptoms, Vaccines, RibavirinAbstract
Rift Valley fever (RVF) is a mosquito borne viral disease that had been firstly revealed in Kenya in 1930. It has now become an endemic in all over multiple African states as well as in Arabian Peninsula. In the early days, RVF was assumed to be geologically restricted to only sub-Saharan Africa, thus, RVF generally had not been considered in the diagnosis of disease epidemics outside of the Africa. The loss of livestock had furthermore threatened the livelihood of people who were dependent on the animals for their food and income. Weakness, chills, headache, fever are considered to be the most common symptoms that arise in the patients suffering from RVF. Nevertheless, the choices for control of the RVF outbreaks have been restricted by the lack of approved human vaccines or other medications. Ribavirin, Favipiravir and various other anti-viral drugs had shown to be effective against the rift valley fever. However, only supportive care had been used for the treatment of the RVF. For that purpose, Rift Valley Fever had now been prioritized by the World Health Organization (WHO) for urgent research and development of countermeasures for the control and prevention of future outbreak. In this review, we had highlighted the outbreak of Rift Valley Fever in various countries, its epidemiology, clinical manifestations, various medications that had been used for the treatment of this infectious disease and also the future prospectives regarding the RVF based on up-to-date data extracted from reputed journals and official websites.
References
Musa TH, Akintunde TY, Musa IH, Mohammed LA, Tassang AE, Musa HH. Rift valley fever: thematic analysis of documents indexed in the Web of Science Core Collection database. Ann. Infect. 2022; 6: 1. doi: 10.21037/aoi-21-9
Bron GM, Strimbu K, Cecilia H, Lerch A, Moore SM, Tran Q, et al. Over 100 years of Rift Valley fever: a patchwork of data on pathogen spread and spillover. Pathogens. 2021 Jun; 10(6). doi: 10.3390/pathogens10060708
Velu RM, Kwenda G, Libonda L, Chisenga CC, Flavien BN, Chilyabanyama ON, et al. Mosquito-Borne Viral Pathogens Detected in Zambia: A Systematic Review. Pathogens. 2021 Aug; 10(8): 1007. doi: 10.3390/pathogens10081007
Anyamba A, Damoah R, Kemp A, Small JL, Rostal MK, Bagge W, et al. Climate Conditions During a Rift Valley Fever Post-epizootic Period in Free State, South Africa, 2014-2019. Frontiers in veterinary science. 2022 Jan; 8: 730424. doi: 10.3389/fvets.2021.730424
Hassan A, Muturi M, Mwatondo A, Omolo J, Bett B, Gikundi S, et al. Epidemiological investigation of a Rift Valley fever outbreak in humans and livestock in Kenya, 2018. The American journal of tropical medicine and hygiene. 2020 Oct; 103(4): 1649-55. doi: 10.4269/ajtmh.20-0387
Gear JH. Rift Valley fever. InCRC Handbook of Viral and Rickettsial Hemorrhagic Fevers . CRC Press. 2019 Jun: 101-118. doi: 10.1201/9780429276736-8
Barry Y, Elbara A, Bollahi MA, El Mamy AB, Fall M, Beyit AD, et al. Rift Valley fever, Mauritania, 2020: Lessons from a one health approach. One Health. 2022 Dec; 15: 100413. doi: 10.1016/j.onehlt.2022.100413
Tong C, Javelle E, Grard G, Dia A, Lacrosse C, Fourié T, et al. Tracking Rift Valley fever: from Mali to Europe and other countries, 2016. Eurosurveillance. 2019 Feb; 24(8): 1800213. doi: 10.2807/1560-7917.ES.2019.24.8.1800213
Cook EA, Grossi-Soyster EN, De Glanville WA, Thomas LF, Kariuki S, Bronsvoort BM, et al. The sero-epidemiology of Rift Valley fever in people in the Lake Victoria Basin of western Kenya. PLoS neglected tropical diseases. 2017 Jul; 11(7): e0005731. doi: 10.1371/journal.pntd.0005731
Hartman AL, Powell DS, Bethel LM, Caroline AL, Schmid RJ, Oury T, et al. Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets. Journal of virology. 2014 Feb; 88(4): 2235-45. doi: 10.1128/JVI.02341-13
Nguku PM, Sharif SK, Mutonga D, Amwayi S, Omolo J, Mohammed O, et al. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007. The American journal of tropical medicine and hygiene. 2010 Aug; 83(2): 05-13 doi: 10.4269/ajtmh.2010.09-0288
Le May N, Dubaele S, De Santis LP, Billecocq A, Bouloy M, Egly JM. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell. 2004 Feb; 116(4): 541-50. doi: 10.1016/S0092-8674(04)00132-1
Al-Hamdan NA, Panackal AA, Al Bassam TH, Alrabea A, Al Hazmi M, Al Mazroa Y, et al. The risk of nosocomial transmission of Rift Valley fever. PLoS neglected tropical diseases. 2015 Dec; 9(12): e0004314. doi: 10.1371/journal.pntd.0004314
Brès P. Impact of arboviruses on human and animal health. InThe arboviruses: epidemiology and ecology. CRC Press; 2020 Mar: 1-18. doi: 10.1201/9780429280221-1
Cecilia H, Drouin A, Métras R, Balenghien T, Durand B, Chevalier V, Ezanno P. Mechanistic models of Rift Valley fever virus transmission dynamics: A systematic review. medRxiv. 2022 Mar: 2022. doi: 10.1101/2022.03.28.22272741
Zouaghi K, Bouattour A, Aounallah H, Surtees R, Krause E, Michel J, et al. First serological evidence of crimean-congo hemorrhagic fever virus and rift valley fever virus in ruminants in tunisia. Pathogens. 2021 Jun; 10(6). doi: 10.3390/pathogens10060769
Endale A, Michlmayr D, Abegaz WE, Geda B, Asebe G, Medhin G, et al. Sero-prevalence of West Nile virus and Rift Valley fever virus infections among cattle under extensive production system in South Omo area, southern Ethiopia. Tropical Animal Health and Production. 2021 Mar; 53: 1-8. doi: 10.1007/s11250-020-02506-0
Cosseddu GM, Doumbia B, Scacchia M, Pinoni C, Di Provvido A, Polci A, et al. Sero-surveillance of emerging viral diseases in camels and cattle in Nouakchott, Mauritania: an abattoir study. Tropical Animal Health and Production. 2021 Jun; 53: 1-6. doi: 10.1007/s11250-021-02636-z
Halawi AA, Saasa N, Pongombo BL, Kajihara M, Chambaro HM, Hity M, et al. Seroprevalence of Rift Valley fever in cattle of smallholder farmers in Kwilu Province in the Democratic Republic of Congo. Tropical animal health and production. 2019 Nov; 51: 2619-27. doi: 10.1007/s11250-019-01978-z
Rogier E, Plucinski M, Candrinho B, Moss DM, Gibbons A, Colborn J, et al. Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014. Journal of Virology. 2022 Aug; 96(16): e00672-22. doi: 10.1128/jvi.00672-22
Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Depner K, Drewe JA, et al. Rift Valley Fever-epidemiological update and risk of introduction into Europe. EFSA Journal. 2020 Mar; 18(3): e06041. doi: 10.2903/j.efsa.2020.6041
Muema C, Ngarega BK, Muturi E, Wei H, Yang H. Present and Future Ecological Niche Modeling of Rift Valley fever in East Africa in Response to Climate Change. bioRxiv. 2021 Mar. doi: 10.1101/2021.03.03.433832
Tucker CJ, Melocik KA, Anyamba A, Linthicum KJ, Fagbo SF, Small JL. Reanalysis of the 2000 Rift Valley fever outbreak in Southwestern Arabia. Plos one. 2020 Dec; 15(12): e0233279. doi: 10.1371/journal.pone.0233279
Sado FY, Tchetgna HS, Kamgang B, Djonabaye D, Nakouné E, McCall PJ, et al. Seroprevalence of Rift Valley fever virus in domestic ruminants of various origins in two markets of Yaoundé, Cameroon. PLoS Neglected Tropical Diseases. 2022 Aug; 16(8): e0010683. doi: 10.1371/journal.pntd.0010683
Javelle E, Lesueur A, Pommier de Santi V, de Laval F, Lefebvre T, Holweck G, et al. The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal. Annals of Clinical Microbiology and Antimicrobials. 2020 Dec; 19(1): 1-8. doi: 10.1186/s12941-020-0346-5
Uwishema O, Adanur I, Babatunde AO, Hasan MM, Elmahi OK, Olajumoke KB, et al. Viral infections amidst COVID‐19 in Africa: implications and recommendations. Journal of medical virology. 2021 Dec; 93(12): 6798-802. doi: 10.1002/jmv.27211
Daubney R and Hudson JR. Enzootic Hepatitis or Rift Valley Fever. An Un-described Virus Disease of Sheep, Cattle and Man from East Africa. Journal of pathology and bacteriology. 1931; 34: 545-79. doi: 10.1002/path.1700340418
Findlay GM and Daubney R. The Virus of Rift Valley Fever or Enzob'tic Hepatitis. Lancet. 1931. doi: 10.1016/S0140-6736(00)99624-7
Swanepoel, R, Manning, B, Watt J. Fatal Rift Valley fever of man in Rhodesia. Central African Journal of Medicine. 1979 Jan; 25(1): 1-8.
El-Shinnawi BM, Sobhy F, El-Zawahry A. Laboratory findings in some cases of Rift Valley fever: histopathological haematological, and biochemical. The Journal of the Egyptian Public Health Association. 1978 Jan; 53(3-4): 187-9.
Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, et al. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology. 2005 Feb; 112(2): 313-8. doi: 10.1016/j.ophtha.2004.09.018
Bird BH and Nichol ST. Breaking the chain: Rift Valley fever virus control via livestock vaccination. Current opinion in virology. 2012 Jun; 2(3): 315-23. doi: 10.1016/j.coviro.2012.02.017
Ellenbecker M, Lanchy JM, Lodmell JS. Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin. Antimicrobial Agents and Chemotherapy. 2014 Dec; 58(12): 7405-15. doi: 10.1128/AAC.03595-14
Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, et al. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral research. 2014 Apr; 104: 84-92. doi: 10.1016/j.antiviral.2014.01.016
Benedict A, Bansal N, Senina S, Hooper I, Lundberg L, de la Fuente C, et al. Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection. Frontiers in microbiology. 2015 Jul; 6. doi: 10.3389/fmicb.2015.00676
Bell TM, Espina V, Senina S, Woodson C, Brahms A, Carey B, Let al. Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis. Antiviral research. 2017 Jul; 143: 162-75. doi: 10.1016/j.antiviral.2017.04.011
Keck F, Amaya M, Kehn-Hall K, Roberts B, Bailey C, Narayanan A. Characterizing the effect of Bortezomib on rift valley fever virus multiplication. Antiviral Research. 2015 Aug; 120: 48-56. doi: 10.1016/j.antiviral.2015.05.004
Bazhanov N, Escaffre O, Freiberg AN, Garofalo RP, Casola A. Broad-range antiviral activity of hydrogen sulfide against highly pathogenic RNA viruses. Scientific reports. 2017 Jan; 7(1): 41029. doi: 10.1038/srep41029
Caplen H, Peters CJ, Bishop DH. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. Journal of General Virology. 1985 Oct; 66(10): 2271-7. doi: 10.1099/0022-1317-66-10-2271
Monath TP. Treatment of yellow fever. Antiviral research. 2008 Apr; 78(1): 116-24. doi: 10.1016/j.antiviral.2007.10.009
Peters CJ, Reynolds JA, Slone TW, Jones DE, Stephen EL. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral research. 1986 Aug; 6(5): 285-97. doi: 10.1016/0166-3542(86)90024-0
Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, et al. Mechanism of action of T-705 against influenza virus. Antimicrobial agents and chemotherapy. 2005 Mar; 49(3): 981-6. doi: 10.1128/AAC.49.3.981-986.2005
Caroline AL, Powell DS, Bethel LM, Oury TD, Reed DS, Hartman AL. Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever. PLoS neglected tropical diseases. 2014 Apr; 8(4): e2790. doi: 10.1371/journal.pntd.0002790
Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine. 1999 Aug; 18(1-2): 181-9. doi: 10.1016/S0264-410X(99)00218-2
Barnard, BJH & Botha MJ. An inactivated rift valley fever vaccine. Journal of the South African Veterinary Association. 1977 Mar; 48(1): 45-8.
Botros B, Omar A, Elian K, Mohamed G, Soliman A, Salib A, et al. Adverse response of non‐indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. Journal of medical virology. 2006 Jun; 78(6): 787-91. doi: 10.1002/jmv.20624
Ahmed A, Mahmoud I, Eldigail M, Elhassan RM, Weaver SC. The emergence of Rift Valley Fever in gedaref state urges the need for a cross-border one health strategy and enforcement of the international health regulations. Pathogens. 2021 Jul; 10(7). doi: 10.3390/pathogens10070885
Chambaro HM, Hirose K, Sasaki M, Libanda B, Sinkala Y, Fandamu P, et al. An unusually long Rift valley fever inter-epizootic period in Zambia: Evidence for enzootic virus circulation and risk for disease outbreak. PLoS neglected tropical diseases. 2022 Jun; 16(6): e0010420. doi: 10.1371/journal.pntd.0010420
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
